Proteolytic control of TGF-b co-receptor activity by BMP-1/ tolloid-like proteases revealed by quantitative iTRAQ proteomics

Cellular and Molecular Life Sciences

Volumn 72, Issue 5, 2015, Pages 1009-1027

  Delolme, Frédéric ^a,b   Anastasi, Cyril ^a   Alcaraz, Lindsay B ^c   Mendoza, Valentin ^d   Vadon Le Goff, Sandrine ^a   Talantikite, Maya ^a   Capomaccio, Robin ^a   Mevaere, Jimmy ^a   Fortin, Laëtitia ^a   Mazzocut, Dominique ^b   Damour, Odile ^a,e   Zanella Cléon, Isabelle ^b   Hulmes, David J S ^a   Overall, Christopher M ^f   Valcourt, Ulrich ^c   Lopez Casillas, Fernando ^d   Moali, Catherine ^a  

^a UNIVERSITÉ DE LYON   (France)

^b INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^c CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^d INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^e HOSPICES CIVILS DE LYON   (France)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

BMP 1 tolloid like proteinases; Degradomics; Glycosaminoglycan; Mass spectrometry; Surface plasmon resonance; Zona pellucida

Indexed keywords

CD109 PROTEIN; CELL PROTEIN; NEUROPILIN 1; PROCOLLAGEN C PROTEINASE; REGULATOR PROTEIN; SMAD2 PROTEIN; TOLLOID METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; UNCLASSIFIED DRUG; CD109 PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; PROTEIN BINDING; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA; TUMOR PROTEIN;

ARTICLE; CELL LINE; CELL SURFACE; CONTROLLED STUDY; CORNEA CELL; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; HT1080 CELL LINE; HUMAN; HUMAN CELL; ISOBARIC TAGS FOR RELATIVE AND ABSOLUTE QUANTIFICATION PROTEOMICS; MASS SPECTROMETRY; METABOLIC REGULATION; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEOMICS; QUANTITATIVE ANALYSIS; ELECTROSPRAY MASS SPECTROMETRY; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIGENS, CD; BONE MORPHOGENETIC PROTEIN 1; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXTRACELLULAR MATRIX; GPI-LINKED PROTEINS; HUMANS; NEOPLASM PROTEINS; NEUROPILIN-1; PEPTIDES; PHOSPHORYLATION; PROTEIN BINDING; PROTEOGLYCANS; PROTEOLYSIS; PROTEOMICS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84926653296     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1733-x     Document Type: Article

References (69)

1. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242:1528-1534
2. Suzuki N, Labosky PA, Furuta Y, Hargett L, Dunn R, Fogo AB, Takahara K, Peters DM, Greenspan DS, Hogan BL (1996) Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by Bmp1, a mammalian gene related to Drosophila tolloid. Development 122:3587-3595
3. Muir AM, Ren Y, Butz DH, Davis NA, Blank RD, Birk DE, Lee SJ, Rowe D, Feng JQ, Greenspan DS (2014) Induced ablation of Bmp1 and Tll1 produces osteogenesis imperfecta in mice. Hum Mol Genet 23(12):3085-3101
4. Asharani PV, Keupp K, Semler O, Wang W, Li Y, Thiele H, Yigit G, Pohl E, Becker J, Frommolt P et al (2012) Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish. Am J Hum Genet 90:661-674
5. Martinez-Glez V, Valencia M, Caparros-Martin JA, Aglan M, Temtamy S, Tenorio J, Pulido V, Lindert U, Rohrbach M, Eyre D et al (2012) Identification of a mutation causing deficient BMP1/ mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta. Hum Mutat 33:343-350
6. Moali C, Hulmes DJ (2009) Extracellular and cell surface proteases in wound healing: new players are still emerging. Eur J Dermatol 19:552-564
7. Grgurevic L, Macek B, Healy DR, Brault AL, Erjavec I, Cipcic A, Grgurevic I, Rogic D, Galesic K, Brkljacic J et al (2011) Circulating bone morphogenetic protein 1-3 isoform increases renal fibrosis. J Am Soc Nephrol 22:681-692
8. Kobayashi K, Luo M, Zhang Y, Wilkes DC, Ge G, Grieskamp T, Yamada C, Liu TC, Huang G, Basson CT et al (2009) Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat Cell Biol 11:46-55
9. Tovar-Vidales T, Fitzgerald AM, Clark AF, Wordinger RJ (2013) Transforming growth factor-beta2 induces expression of biologically active bone morphogenetic protein-1 in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 54:4741-4748
10. Lopez B, Gonzalez A, Beaumont J, Querejeta R, Larman M, Diez J (2007) Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure. J Am Coll Cardiol 50:859-867
11. Moali C, Hulmes DJ (2012) Roles and regulation of BMP-1/ tolloid-like proteinases : collagen/matrix assembly, growth factor activation and beyond. In: Karamanos M (ed) Extracellular matrix : pathobiology and signaling. De Gruyter, Berlin
12. Muir A, Greenspan DS (2011) Metalloproteinases in Drosophila to humans that are central players in developmental processes. J Biol Chem 286:41905-41911
13. Ge G, Greenspan DS (2006) BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein. J Cell Biol 175:111-120
14. Lee S, Solow-Cordero DE, Kessler E, Takahara K, Greenspan DS (1997) Transforming growth factor-beta regulation of bone morphogenetic protein-1/procollagen C-proteinase and related proteins in fibrogenic cells and keratinocytes. J Biol Chem 272:19059-19066
15. Wu MY, Hill CS (2009) TGF-beta superfamily signaling in embryonic development and homeostasis. Dev Cell 16:329-343
16. Akhurst RJ, Hata A (2012) Targeting the TGFbeta signalling pathway in disease. Nat Rev Drug Discov 11:790-811
17. Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577-584
18. Wang XF, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA (1991) Expression cloning and characterization of the TGF-beta type III receptor. Cell 67:797-805
19. Lopez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massague J (1991) Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 67:785-795
20. Gougos A, Letarte M (1988) Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J. Immunol. 141:1925-1933
21. Gougos A, Letarte M (1990) Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 265:8361-8364
22. Finnson KW, Tam BY, Liu K, Marcoux A, Lepage P, Roy S, Bizet AA, Philip A (2006) Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes. FASEB J. 20:1525-1527
23. Bizet AA, Liu K, Tran-Khanh N, Saksena A, Vorstenbosch J, Finnson KW, Buschmann MD, Philip A (2011) The TGF-beta coreceptor, CD109, promotes internalization and degradation of TGF-beta receptors. Biochim Biophys Acta 1813:742-753
24. Glinka Y, Prud'homme GJ (2008) Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J Leukoc Biol 84:302-310
25. Glinka Y, Stoilova S, Mohammed N, Prud'homme GJ (2011) Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. Carcinogenesis 32:613-621
26. Cackowski FC, Xu L, Hu B, Cheng SY (2004) Identification of two novel alternatively spliced Neuropilin-1 isoforms. Genomics 84:82-94
27. Hagiwara S, Murakumo Y, Mii S, Shigetomi T, Yamamoto N, Furue H, Ueda M, Takahashi M (2010) Processing of CD109 by furin and its role in the regulation of TGF-beta signaling. Oncogene 29:2181-2191
28. Litvinov IV, Bizet AA, Binamer Y, Jones DA, Sasseville D, Philip A (2011) CD109 release from the cell surface in human keratinocytes regulates TGF-beta receptor expression, TGF-beta signalling and STAT3 activation: relevance to psoriasis. Exp Dermatol 20:627-632
29. Lopez-Casillas F, Payne HM, Andres JL, Massague J (1994) Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites. J Cell Biol 124:557-568
30. Velasco-Loyden G, Arribas J, Lopez-Casillas F (2004) The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1. J Biol Chem 279:7721-7733
31. Dean RA, Overall CM (2007) Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. Mol Cell Proteomics 6:611-623
32. Bandyopadhyay A, Lopez-Casillas F, Malik SN, Montiel JL, Mendoza V, Yang J, Sun LZ (2002) Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft. Cancer Res 62:4690-4695
33. Vilchis-Landeros MM, Montiel JL, Mendoza V, Mendoza-Hernandez G, Lopez-Casillas F (2001) Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agent. Biochem J 355:215-222
34. Bijakowski C, Vadon-Le GS, Delolme F, Bourhis JM, Lecorche P, Ruggiero F, Becker-Pauly C, Yiallouros I, Stocker W, Dive V et al (2012) Sizzled is unique among secreted frizzled-related proteins for its ability to specifically inhibit bone morphogenetic protein-1 (BMP-1)/tolloid-like proteinases. J Biol Chem 287:33581-33593
35. Moali C, Font B, Ruggiero F, Eichenberger D, Rousselle P, Francois V, Oldberg A, Bruckner-Tuderman L, Hulmes DJ (2005) Substrate-specific modulation of a multisubstrate proteinase. C-terminal processing of fibrillar procollagens is the only BMP-1-dependent activity to be enhanced by PCPE-1. J Biol Chem 280:24188-24194
36. Broder C, Arnold P, Vadon-Le GS, Konerding MA, Bahr K, Muller S, Overall CM, Bond JS, Koudelka T, Tholey A et al (2013) Metalloproteases meprin alpha and meprin beta are C- and N-procollagen proteinases important for collagen assembly and tensile strength. Proc Natl Acad Sci USA 110:14219-14224
37. Doucet A, Overall CM (2011) Broad coverage identification of multiple proteolytic cleavage site sequences in complex high molecular weight proteins using quantitative proteomics as a complement to edman sequencing. Mol Cell Proteomics 10(M110):003533
38. Deutsch EW, Mendoza L, Shteynberg D, Farrah T, Lam H, Tasman N, Sun Z, Nilsson E, Pratt B, Prazen B et al (2010) A guided tour of the Trans-Proteomic Pipeline. Proteomics 10:1150-1159
39. Keller A, Shteynberg D (2011) Software pipeline and data analysis for MS/MS proteomics: the trans-proteomic pipeline. Methods Mol Biol 694:169-189
40. Vizcaino JA, Cote RG, Csordas A, Dianes JA, Fabregat A, Foster JM, Griss J, Alpi E, Birim M, Contell J et al (2013) The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res 41:D1063-D1069
41. Builles N, Bechetoille N, Justin V, Ducerf A, Auxenfans C, Burillon C, Sergent M, Damour O (2006) Development of an optimised culture medium for keratocytes in monolayer. Biomed Mater Eng 16:S95-S104
42. Turtle E, Chow N, Yang C, Sosa S, Bauer U, Brenner M, Solow- Cordero D, Ho WB (2012) Design and synthesis of procollagen C-proteinase inhibitors. Bioorg Med Chem Lett 22:7397-7401
43. Garrigue-Antar L, Barker C, Kadler KE (2001) Identification of amino acid residues in bone morphogenetic protein-1 important for procollagen C-proteinase activity. J Biol Chem 276:26237-26242
44. Dennler S, Itoh S, Vivien D, ten DP, Huet S, Gauthier JM (1998) Direct binding of Smad3 and Smad4 to critical TGF betainducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17:3091-3100
45. Pommier RM, Gout J, Vincent DF, Cano CE, Kaniewski B, Martel S, Rodriguez J, Fourel G, Valcourt U, Marie JC et al (2012) The human NUPR1/P8 gene is transcriptionally activated by transforming growth factor beta via the SMAD signalling pathway. Biochem J 445:285-293
46. Massague J (1987) Identification of receptors for type-beta transforming growth factor. Methods Enzymol 146:174-195
47. Lopez-Casillas F, Wrana JL, Massague J (1993) Betaglycan presents ligand to the TGF beta signaling receptor. Cell 73:1435-1444
48. Evans C, Noirel J, Ow SY, Salim M, Pereira-Medrano AG, Couto N, Pandhal J, Smith D, Pham TK, Karunakaran E et al (2012) An insight into iTRAQ: where do we stand now? Anal Bioanal Chem 404:1011-1027
49. Unwin RD, Griffiths JR, Whetton AD (2010) Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC-MS/MS. Nat Protoc 5:1574-1582
50. Amano S, Scott IC, Takahara K, Koch M, Champliaud MF, Gerecke DR, Keene DR, Hudson DL, Nishiyama T, Lee S et al (2000) Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain. J Biol Chem 275:22728-22735
51. Solomon KR, Sharma P, Chan M, Morrison PT, Finberg RW (2004) CD109 represents a novel branch of the alpha2-macroglobulin/ complement gene family. Gene 327:171-183
52. Andres JL, Stanley K, Cheifetz S, Massague J (1989) Membraneanchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta. J Cell Biol 109:3137-3145
53. Lin SJ, Hu Y, Zhu J, Woodruff TK, Jardetzky TS (2011) Structure of betaglycan zona pellucida (ZP)-C domain provides insights into ZP-mediated protein polymerization and TGF-beta binding. Proc. Natl. Acad. Sci. U. S. A 108:5232-5236
54. Monne M, Han L, Schwend T, Burendahl S, Jovine L (2008) Crystal structure of the ZP-N domain of ZP3 reveals the core fold of animal egg coats. Nature 456:653-657
55. Fortelny N, Cox J, Lange PF, Kappelhof R, Pavlidis P, Overall CM (2014) Network analyses reveal pervasive functional regulation between proteases in the human protease web. PLoS Biol 12:e1001869
56. Mendoza V, Vilchis-Landeros MM, Mendoza-Hernandez G, Huang T, Villarreal MM, Hinck AP, Lopez-Casillas F, Montiel JL (2009) Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor. Biochemistry 48:11755-11765
57. Boivin WA, Shackleford M, Vanden HA, Zhao H, Hackett TL, Knight DA, Granville DJ (2012) Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-beta1. PLoS One 7:e33163
58. Lamarre J, Vasudevan J, Gonias SL (1994) Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factorbeta complex from the cell surface. Biochem J 302(Pt 1):199-205
59. Kirkbride KC, Townsend TA, Bruinsma MW, Barnett JV, Blobe GC (2008) Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. J Biol Chem 283:7628-7637
60. Esparza-Lopez J, Montiel JL, Vilchis-Landeros MM, Okadome T, Miyazono K, Lopez-Casillas F (2001) Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A. J Biol Chem 276:14588-14596
61. Leighton M, Kadler KE (2003) Paired basic/Furin-like proprotein convertase cleavage of Pro-BMP-1 in the trans-Golgi network. J Biol Chem 278:18478-18484
62. Hanks BA, Holtzhausen A, Evans KS, Jamieson R, Gimpel P, Campbell OM, Hector-Greene M, Sun L, Tewari A, George A et al (2013) Type III TGF-beta receptor downregulation generates an immunotolerant tumor microenvironment. J Clin Invest 123:3925-3940
63. Naba A, Clauser KR, Lamar JM, Carr SA, Hynes RO (2014) Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters. Elife 3:e01308
64. Clark TG, Conway SJ, Scott IC, Labosky PA, Winnier G, Bundy J, Hogan BL, Greenspan DS (1999) The mammalian Tolloid-like 1 gene, Tll1, is necessary for normal septation and positioning of the heart. Development 126:2631-2642
65. Stenvers KL, Tursky ML, Harder KW, Kountouri N, matayakul- Chantler S, Grail D, Small C, Weinberg RA, Sizeland AM, Zhu HJ (2003) Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos. Mol Cell Biol 23:4371-4385
66. Malecaze F, Massoudi D, Fournié P, Tricoire C, Cassagne M, Malbouyres M, Hulmes DJ, Moali C, Galiacy S (2014) Up-regulation of bone morphogenetic protein-1/mammalian tolloid and procollagen C-proteinase enhancer-1 in corneal scarring. Invest Ophthalmol Vis Sci in press
67. Stramer BM, Zieske JD, Jung JC, Austin JS, Fini ME (2003) Molecular mechanisms controlling the fibrotic repair phenotype in cornea: implications for surgical outcomes. Invest Ophthalmol Vis Sci 44:4237-4246
68. Liang H, Zhang C, Ban T, Liu Y, Mei L, Piao X, Zhao D, Lu Y, Chu W, Yang B (2012) A novel reciprocal loop between microRNA- 21 and TGFbetaRIII is involved in cardiac fibrosis. Int J Biochem Cell Biol 44:2152-2160
69. Ahn JY, Park S, Yun YS, Song JY (2010) Inhibition of type III TGF-beta receptor aggravates lung fibrotic process. Biomed Pharmacother 64:472-476